NCT07128342View on ClinicalTrials.gov

CGM Use in Non-insulin Patients With DM2

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2028

Conditions
DiabetesType 2 Diabetes (T2DM)Obesity Type 2 Diabetes MellitusNon Insulin Dependent Diabetes Mellitus
Interventions
DEVICE

CGM Group

This group of patients will receive a CGM device to monitor their blood glucoses

DEVICE

FSBG group

This group of patients will receive a fingerstick blood glucose (FSBG) device for glucose monitoring

All Listed Sponsors
lead

Milwaukee VA Medical Center

FED